Dr. Kris Mahadeo, MD

• Pediatric Hematology & Oncology

• Pediatrics

*Healthgrades does not verify qualifications for medical specialties. Please verify your provider's specialty and qualifications directly with your provider and applicable medical board.

• St. Georges University School Of Medicine

  Medical School, 2003

• IL12 immune therapy clinical trial review: Novel strategies for avoiding CRS-associated cytokines, 2022-09-20

• Management of Aggressive Non-Hodgkin Lymphomas in the Pediatric, Adolescent, and Young Adult Population: An Adult vs. Pediatric Perspective, 2022-06-13

• Extracorporeal membrane oxygenation in children receiving hematopoietic stem cell transplantation and immune effector cell therapies: An International and Multi-Disciplinary Consensus Statement, 2021-12-09

• Cardiac Relapse of Acute Lymphoblastic Leukemia Following Hematopoietic Stem Cell Transplantation: A Case Report and Review of Literature, 2021-11-19

• Perspective: A Framework to Screen Pediatric and Adolescent Hematopoietic Cellular Therapy Patients for Organ Dysfunction: Time for a Multi-Disciplinary and Longitudinal Approach, 2021-02-24

• Corrigendum: Perspective: A Framework to Screen Pediatric and Adolescent Hematopoietic Cellular Therapy Patients for Organ Dysfunction: Time for a Multi-Disciplinary and Longitudinal Approach, 2021-04-23

• The TKI Era in Chronic Leukemias, 2021-12-20

• Using the MDASI-Adolescent for Early Symptom Identification and Mitigation of Symptom Impact on Daily Living in Adolescent and Young Adult Stem Cell Transplant Patients, 2021-12-29

• Prior COVID-19 infection may increase risk for developing endothelial dysfunction following hematopoietic cell transplantation, 2023-01-17

• Case Discussion and Literature Review: Cancer Immunotherapy, Severe Immune-Related Adverse Events, Multi-Inflammatory Syndrome, and Severe Acute Respiratory Syndrome Coronavirus 2, 2021-02-04

• Chimeric Antigen Receptor, Teamwork, Education, Assessment, and Management (CAR-TEAM): A Simulation-Based Inter-professional Education (IPE) Intervention for Management of CAR Toxicities, 2020-08-05

• The Organ Trail: A Review of Biomarkers of Organ Failure, 2020-11-11

• Risk Factors for Noninvasive Ventilation Failure in Children Post-Hematopoietic Cell Transplant, 2021-05-27

• Feasibility and Acceptability Findings of an Energy Balance Data Repository of Children, Adolescents, and Young Adults with Cancer, 2020-09-06

• Autologous CD33-CAR-T cells for treatment of relapsed/refractory acute myelogenous leukemia, 2021-04-08

• Immune Effector Cell Associated Neurotoxicity (ICANS) in Pediatric and Young Adult Patients Following Chimeric Antigen Receptor (CAR) T-Cell Therapy: Can We Optimize Early Diagnosis?, 2021-03-08

• Diagnosis, grading and management of toxicities from immunotherapies in children, adolescents and young adults with cancer, 2021-02-19

• Management guidelines for paediatric patients receiving chimeric antigen receptor T cell therapy, 2018-08-06

• The Evolution of Chimeric Antigen Receptor T-Cell Therapy in Children, Adolescents and Young Adults with Acute Lymphoblastic Leukemia, 2022-09-14

• Venetoclax for Children and Adolescents with Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma, 2021-12-29

• A multicenter study of ICU resource utilization in pediatric, adolescent and young adult patients post CAR-T therapy, 2022-10-24

• 15. Evaluation of Retained Immunity forTetanus-DiphtheriaandPneumococcalVaccines in Recipients of Cellular Therapies, 2021-12-04

• Tumor-targeted IL-12 combined with tumor resection yields a survival-favorable immune profile, 2019-06-17

• High-Risk Acute Myeloid Leukemia: A Pediatric Prospective, 2022-06-14

• Complete remission in refractory acute lymphoblastic leukemia using blinatumomab after failure of response to CD-19 chimeric antigen receptor T-cell therapy, 2020-05-28

• Retrospective Review of Flexible Bronchoscopy in Pediatric Cancer Patients, 2021-12-14